Literature DB >> 15316645

[Pulmonary thromboendarterectomy].

H F Lausberg1, D Tscholl, H-J Schäfers.   

Abstract

Chronic thromboembolic pulmonary hypertension with concomitant right heart failure may develop as a sequela of acute pulmonary embolism with organization instead of thrombolysis of intravascular clots. Medical therapy aims at prevention of recurrent embolism by anticoagulation and vascular remodelling using vasodilator therapy. Lung transplantation or combined heart-lung transplantation is associated with unsatisfactory long-term results and comorbidity and therefore remains justified only in selected patients. Pulmonary thromboendarterectomy allows specific treatment of intravascular obstruction. This closed endarterectomy of the pulmonary arteries requires deep hypothermic circulatory arrest and can be performed with a perioperative mortality of less than 10%. The procedure significantly decreases pulmonary vascular resistance and often normalizes pulmonary hemodynamics and gas exchange. Postoperatively the patients' clinical condition improves and the majority have normal exercise capacity and activity.

Entities:  

Mesh:

Year:  2004        PMID: 15316645     DOI: 10.1007/s00101-004-0725-x

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  13 in total

1.  Long-term outcome after pulmonary thromboendarterectomy.

Authors:  C J Archibald; W R Auger; P F Fedullo; R N Channick; K M Kerr; S W Jamieson; D P Kapelanski; C N Watt; K M Moser
Journal:  Am J Respir Crit Care Med       Date:  1999-08       Impact factor: 21.405

Review 2.  Chronic thromboembolic pulmonary hypertension.

Authors:  P F Fedullo; W R Auger; K M Kerr; L J Rubin
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

3.  Intraoperative inhalation of the long-acting prostacyclin analog iloprost for pulmonary hypertension.

Authors:  Frank Langer; Wolfram Wilhelm; Dietmar Tscholl; Rene Schramm; Henning Lausberg; Olaf Wendler; Hans-Joachim Schäfers
Journal:  J Thorac Cardiovasc Surg       Date:  2003-09       Impact factor: 5.209

Review 4.  Chronic major-vessel thromboembolic pulmonary hypertension.

Authors:  K M Moser; W R Auger; P F Fedullo
Journal:  Circulation       Date:  1990-06       Impact factor: 29.690

5.  Chronic thromboembolic pulmonary hypertension: CT findings.

Authors:  M A King; M Ysrael; C J Bergin
Journal:  AJR Am J Roentgenol       Date:  1998-04       Impact factor: 3.959

6.  Prognostic factors in medically treated patients with chronic pulmonary embolism.

Authors:  J Lewczuk; P Piszko; J Jagas; A Porada; S Wójciak; B Sobkowicz; K Wrabec
Journal:  Chest       Date:  2001-03       Impact factor: 9.410

7.  Postoperative management of the patient undergoing pulmonary thromboendarterectomy.

Authors:  P F Fedullo; W R Auger; W P Dembitsky
Journal:  Semin Thorac Cardiovasc Surg       Date:  1999-04

8.  Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension: changes after pulmonary thromboendarterectomy.

Authors:  T Menzel; S Wagner; T Kramm; S Mohr-Kahaly; E Mayer; S Braeuninger; J Meyer
Journal:  Chest       Date:  2000-10       Impact factor: 9.410

9.  Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data.

Authors:  M Riedel; V Stanek; J Widimsky; I Prerovsky
Journal:  Chest       Date:  1982-02       Impact factor: 9.410

10.  Modifications of techniques and early results of pulmonary thromboendarterectomy for chronic pulmonary embolism.

Authors:  P O Daily; W P Dembitsky; K L Peterson; K M Moser
Journal:  J Thorac Cardiovasc Surg       Date:  1987-02       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.